LTRN

NASDAQStock

Lantern Pharma Inc.

$2.39-0.14 (-5.53%)

52-Week Range

$2.53

$5.32

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.53

Volume

54.4K

Avg Volume

62.9K

Performance

-5.95%

-24.93%

-33.60%

YTD

-18.65%

-33.42%

-45.36%

-86.78%

Price Chart

ETF Exposure

LTRN is held by 13 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
MEDX	Horizon Kinetics Medical ETF	0.37%	27,582	$70K	$19.6M	0.85%
IWC	iShares Micro-Cap ETF	0.01%	21,514	$58K	$1.27B	0.60%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	4	$10	$2.68B	0.14%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	1,042	$3K	$40.55B	0.17%
DFSU	Dimensional - US Sustainability Core 1 ETF	0.00%	1,924	$5K	$1.87B	0.15%
DXUV	Dimensional - US Vector Equity ETF	0.00%	4	$10	$351.7M	0.28%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	12	$52	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	440	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	2	$9	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	250,635	$790K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,318	$6K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	113	$484	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	81,444	$257K	$84.10B	0.05%

About LTRN ETF Exposure

Lantern Pharma Inc. (LTRN) is held by 13 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $2.39. Investors can gain exposure to LTRN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LTRN, sorted by portfolio weight.